Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Angion Biomedica Pulls The Plug On Another Kidney Disease Trial - Read Why

Angion Biomedica Corp (NASDAQ:ANGN) has discontinued the JUNIPER Phase 2 trial of ANG-3070, an oral tyrosine kinase inhibitor, in primary proteinuric kidney diseases, specifically focal segmental glomerulosclerosis and immunoglobulin A nephropathy. The trial began enrolling patients in December 2021. A reassessment was conducted following a potential safety signal of an unexpected and substantial…

Benzinga

US Stock Futures Down Ahead Of Jobless Claims Data

Pre-open movers

Benzinga

Polestar Shares Down 25 Percent Four Days After Nasdaq Debut

Polestar rang the Nasdaq opening bell on June 28.

InsideEVs

From analysis to the latest developments in health,
read the most diverse news in one place.

This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering.

Benzinga

Why China's JD Is Giving Rival Tech Giant Tencent An Additional $220M Stake

Chinese e-commerce giant JD.Com Inc (NASDAQ: JD) on Wednesday said that it renewed its strategic cooperation agreement with the tech and gaming giant Tencent Holdings (OTC: TCEHY) for a period of three years.

Benzinga

Coinbase Provides Crypto Geo Tracking Data To Homeland Security's ICE: Report

Cryptocurrency exchange Coinbase Global Inc (NASDAQ: COIN) is reportedly selling the Immigrations and Customs Enforcement (ICE) data that aids in tracing cryptocurrency transactions.

Benzinga

Your Apple Card Can Help Get Discounts On Ray-Bans, Crocs Sandals

Users of Apple Card, a credit card from Apple Inc (NASDAQ: AAPL), can get 4% Daily Cash on online or in-app purchases on spending at StubHub, Crocs, Ray-Ban, and more.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Amid 'Existential Priority,' Coinbase Seeks To Accelerate Europe Expansion

San Francisco-based cryptocurrency exchange Coinbase Global Inc (NASDAQ: COIN) is reportedly doubling down on its overseas expansion, registering in markets including Italy, Spa

Benzinga

Spirit Airlines Defers Key Shareholder Vote On Frontier Deal Again

Spirit Airlines Inc (NYSE: SAVE) on Wednesday postponed a key shareholder vote on a proposed deal with Frontier Group Holding Inc (NASDAQ: ULCC) until next week.

Benzinga

Exclusive: Golden Matrix Looks To Esports Wagering, Acquisitions To Continue Growth As Core Business Posts 15 Straight Quarters Of Profitability

A new peer-to-peer system for betting in the esports industry is among the growth items for gaming technology company Golden Matrix Group (NASDAQ: GMGI).

Benzinga

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $19,000 Today

Lululemon Athletica (NASDAQ:LULU) has outperformed the market over the past 15 years by 15.34% on an annualized basis producing an average annual return of 21.64%. Currently, Lululemon Athletica has a market capitalization of $36.12 billion.

Benzinga

Here's How Much You Would Have Made Owning Lam Research Stock In The Last 5 Years

Lam Research (NASDAQ:LRCX) has outperformed the market over the past 5 years by 15.15% on an annualized basis producing an average annual return of 24.54%. Currently, Lam Research has a market capitalization of $59.24 billion.

Benzinga

Expert Ratings for Plug Power

Plug Power (NASDAQ:PLUG) has observed the following analyst ratings within the last quarter:

Benzinga

What 6 Analyst Ratings Have To Say About Grocery Outlet Holding

Within the last quarter, Grocery Outlet Holding (NASDAQ:GO) has observed the following analyst ratings:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Expert Ratings for ON Semiconductor

Within the last quarter, ON Semiconductor (NASDAQ:ON) has observed the following analyst ratings:

Benzinga

Analyst Ratings for Broadcom

Broadcom (NASDAQ:AVGO) has observed the following analyst ratings within the last quarter:

Benzinga

Where Affirm Holdings Stands With Analysts

Analysts have provided the following ratings for Affirm Holdings (NASDAQ:AFRM) within the last quarter:

Benzinga

What 14 Analyst Ratings Have To Say About Ambarella

Analysts have provided the following ratings for Ambarella (NASDAQ:AMBA) within the last quarter:

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What 4 Analyst Ratings Have To Say About Hamilton Lane

Hamilton Lane (NASDAQ:HLNE) has observed the following analyst ratings within the last quarter:

Benzinga

What Are Whales Doing With CrowdStrike Holdings

A whale with a lot of money to spend has taken a noticeably bullish stance on CrowdStrike Holdings. Looking at options history for CrowdStrike Holdings (NASDAQ:CRWD) we detected 14 strange trades.

Benzinga

Where Teradyne Stands With Analysts

Analysts have provided the following ratings for Teradyne (NASDAQ:TER) within the last quarter:

Benzinga

What 14 Analyst Ratings Have To Say About Advanced Micro Devices

Within the last quarter, Advanced Micro Devices (NASDAQ:AMD) has observed the following analyst ratings:

Benzinga

Better Tips For Uber Drivers, Consider Getting A Tesla

Ride-share drivers are turning to renting or buying electric vehicles. The move, which was being done to help combat high prices for gas at the pump, is turning into higher tips for some drivers as well.

Benzinga

Duck Creek Technologies Shares Crack After Q3 Results, Lowers FY22 Revenue Guidance

Duck Creek Technologies Inc (NASDAQ: DCT) reported

Benzinga

Corcept Therapeutics Commences Late-Stage Ovarian Cancer Study

Corcept Therapeutics (NASDAQ: CORT) has initiated pivotal Phase 3 clinical trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer.

1 … 353 354 355 356

Organisations

Advanced Micro Devices

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.